Efficacy and safety of Anluohuaxian in the treatment of patients with severe Coronavirus disease 2019- a multicenter, open label, randomized controlled study: a structured summary of a study protocol for a randomised controlled trial

Peer Review reports

Original Submission
7 May 2020	Submitted	Original manuscript
7 May 2020	Reviewed	Reviewer Report - Kirsty Loudon
Resubmission - Version 2
	Submitted	Manuscript version 2
Publishing
9 May 2020	Editorially accepted
8 Jun 2020	Article published	10.1186/s13063-020-04399-8

Back to article page